Evidence map›Paper›PMID 36055989›Full record

ArticleCell death & disease2022

Astrocytic SARM1 promotes neuroinflammation and axonal demyelination in experimental autoimmune encephalomyelitis through inhibiting GDNF signaling.

Lingting Jin, Jingjing Zhang, Xin Hua, Xingxing Xu, Jia Li, Jiaojiao Wang, Mianxian Wang, Huitao Liu, Haoyu Qiu, Man Chen and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Neurotrophic factors in multiple sclerosis.Frontiers in immunology · 2025
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Lingting Jin *Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Jingjing Zhang *School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.ORCID http://orcid.org/0000-0001-7524-8973
Xin Hua *School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Xingxing XuSchool of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Jia LiDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Jiaojiao WangSchool of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Mianxian WangSchool of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Huitao LiuSchool of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Haoyu QiuSchool of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Man ChenSchool of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Xu ZhangDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. drzhangxu@live.cn.ORCID http://orcid.org/0000-0002-3680-513X
Ying WangClinical Research Center, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China. nancywangying@163.com.ORCID http://orcid.org/0000-0003-2121-7025
Zhihui HuangDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. huang0069@hznu.edu.cn.ORCID http://orcid.org/0000-0002-1927-0946
Wenzhou Medical University · CNHangzhou First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Astrocytes are important components of the innate immune response in the central nervous system (CNS), involving in the inflammatory and neurotoxic responses that occur in CNS diseases, such as multiple sclerosis (MS). Recent studies have shown that SARM1 plays a critical role in axonal degeneration and inflammation. However, the detailed role of astrocytic SARM1 in MS remains unclear. Here, we established the MS model of mice - experimental autoimmune encephalomyelitis (EAE) and found that SARM1 was upregulated in astrocytes of the spinal cords of EAE mice. Moreover, conditional knockout of astrocytic SARM1 (SARM1

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisAnimalsArmadillo Domain ProteinsAstrocytesCytoskeletal ProteinsGlial Cell Line-Derived Neurotrophic FactorMiceMice, Inbred C57BLMice, KnockoutNeuroinflammatory DiseasesSpinal CordArmadillo Domain ProteinsCytoskeletal ProteinsGdnf protein, mouseGlial Cell Line-Derived Neurotrophic FactorSARM1 protein, mouse

Identifiers

PMID36055989
PMCPMC9440144
OpenAlexW4294238269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.